Archived Insight | January 31, 2018

Spending Law Delays Cadillac Tax and Suspends Other ACA Taxes

On January 22, 2018, President Trump signed into law spending legislation to fund the federal government through February 8, 2018. The law, known as a Continuing Resolution (CR), resulted in the government reopening after a three-day shutdown. The CR delays or suspends two Affordable Care Act taxes that directly affect employer-sponsored plans: the 40 percent excise tax on high-cost plans (the “Cadillac tax”) and the health insurance premium tax. It also suspends the medical device tax.

This Update summarizes the health provisions in the CR and notes the implications for plan sponsors.

Spending Law Delays Cadillac Tax and Suspends Other ACA Taxes

Get the full insight

See more insights

Asia Female Pharmacist Using Digital Tablet While Taking Inventory

New Requirements for PBM Reporting and Fee Disclosures

The Consolidated Appropriations Act of 2026 makes significant reforms to pharmacy benefit manager practices. See the impact on health plan sponsors.

Compliance, Health, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Corporate, Pharmaceutical

Read Full Insight

Human First. AI Forward.

AI is reshaping business—are you ready? Get clarity & actionable steps in our upcoming webinar.

Technology, Benefits Administration, Communications, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Consulting Innovation, Corporate, Benefits Technology, ATC, Organizational Effectiveness, Health, Retirement, Artificial Intelligence

Watch the webinar

Couple Calculating Bills At Home Using Tablet And Calculator

Proposed Rule on Healthcare Price Transparency Disclosures

A proposed rule would change price transparency requirements for health plans and health insurers, including updated machine-readable file standards.

Health, Compliance, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Pharmaceutical, Corporate

Read Full Insight

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.